» Articles » PMID: 30784557

Traumatic Brain Injury in China

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2019 Feb 21
PMID 30784557
Citations 186
Authors
Affiliations
Soon will be listed here.
Abstract

China has more patients with traumatic brain injury (TBI) than most other countries in the world, making this condition a major public health concern. Population-based mortality of TBI in China is estimated to be approximately 13 cases per 100 000 people, which is similar to the rates reported in other countries. The implementation of various measures, such as safety legislation for road traffic, establishment of specialised neurosurgical intensive care units, and the development of evidence-based guidelines, have contributed to advancing prevention and care of patients with TBI in China. However, many challenges remain, which are augmented further by regional differences in TBI care. High-level care, such as intracranial pressure monitoring, is not universally available yet. In the past 30 years, the quality of TBI research in China has substantially improved, as evidenced by an increasing number of clinical trials done. The large number of patients with TBI and specialised trauma centres offer unique opportunities for TBI research in China. Furthermore, the formation and development of research collaborations between China and international groups are considered essential to advancing the quality of TBI care and research in China, and to improve quality of life in patients with this condition.

Citing Articles

Detection of NLRP3, ASC, and Caspase-1 in serum and cerebrospinal fluid of traumatic brain injury patients: implications for short-term prognosis.

Aihemaitiniyazi A, Ma K, Xu J, Chen H, Liu X, Li J Acta Neurol Belg. 2025; .

PMID: 40067654 DOI: 10.1007/s13760-025-02761-8.


CPCGI Alleviates Neural Damage by Modulating Microglial Pyroptosis After Traumatic Brain Injury.

Yu L, Sun L, Yu T, Guo A, Wu J, Chen J CNS Neurosci Ther. 2025; 31(3):e70322.

PMID: 40059065 PMC: 11890976. DOI: 10.1111/cns.70322.


Responsive nanoparticles synergize with Curcumin to break the "reactive oxygen Species-Neuroinflammation" vicious cycle, enhancing traumatic brain injury outcomes.

Fu X, Zhang Y, Chen G, Mao G, Tang J, Xu J J Nanobiotechnology. 2025; 23(1):172.

PMID: 40045354 PMC: 11881390. DOI: 10.1186/s12951-025-03251-y.


C-reactive protein to albumin ratio and Glasgow Coma Scale score as the predictors for weaning outcomes in traumatic brain injury.

Zeng J, Liu J, Lu Y, Fu J, Han D, Chen J Ann Med. 2025; 57(1):2472866.

PMID: 40034061 PMC: 11881653. DOI: 10.1080/07853890.2025.2472866.


Lyophilized Small Extracellular Vesicles (sEVs) Derived from Human Adipose Stem Cells Maintain Efficacy to Promote Healing in Neuronal Injuries.

Jones B, Patel R, Wang B, Evans-Nguyen T, Patel N Biomedicines. 2025; 13(2).

PMID: 40002689 PMC: 11853053. DOI: 10.3390/biomedicines13020275.